{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T19:14:46Z","timestamp":1791832486953,"version":"4.3.4"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000403","name":"Meningitis Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000403","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jinf.2016.03.012","type":"journal-article","created":{"date-parts":[[2016,3,27]],"date-time":"2016-03-27T06:51:47Z","timestamp":1459061507000},"page":"63-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution"],"prefix":"10.1016","volume":"73","author":[{"given":"Stephen A.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8036-2911","authenticated-orcid":false,"given":"Aiswarya","family":"Lekshmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Lucidarme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"How","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lee-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin U.","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne S.","family":"Newbold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annaliesa S.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2016.03.012_bib1","doi-asserted-by":"crossref","first-page":"B26","DOI":"10.1016\/j.vaccine.2011.12.032","article-title":"The changing and dynamic epidemiology of meningococcal disease","volume":"30","author":"Halperin","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.03.012_bib2","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.4161\/hv.24689","article-title":"Meningococcal group B vaccines","volume":"9","author":"Findlow","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2016.03.012_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.4161\/hv.23222","article-title":"Potential impact of the bivalent rLP2806 vaccine on Neisseria meningitidis carriage and invasive serogroup B disease","volume":"9","author":"Anderson","year":"2013","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jinf.2016.03.012_bib4","doi-asserted-by":"crossref","first-page":"6086","DOI":"10.1016\/j.vaccine.2010.06.083","article-title":"Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease","volume":"28","author":"Jiang","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.03.012_bib5","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","article-title":"Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment","volume":"13","author":"Vogel","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2016.03.012_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4049\/jimmunol.177.1.501","article-title":"The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance","volume":"177","author":"Madico","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.jinf.2016.03.012_bib7","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1128\/IAI.72.4.2088-2100.2004","article-title":"Vaccine potential of the Neisseria meningitidis 2086 lipoprotein","volume":"72","author":"Fletcher","year":"2004","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2016.03.012_bib8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1084\/jem.20021911","article-title":"Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870","volume":"197","author":"Masignani","year":"2003","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2016.03.012_bib9","doi-asserted-by":"crossref","first-page":"4739","DOI":"10.1016\/j.vaccine.2011.04.092","article-title":"Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.03.012_bib10","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1128\/CVI.00027-10","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine","volume":"17","author":"Lucidarme","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2016.03.012_bib11","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1086\/600141","article-title":"Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis","volume":"200","author":"Murphy","year":"2009","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jinf.2016.03.012_bib12","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1128\/CVI.00055-11","article-title":"Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein","volume":"18","author":"Lucidarme","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.jinf.2016.03.012_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jinf.2013.06.007","article-title":"Added value of PCR-testing for confirmation of invasive meningococcal disease in England","volume":"67","author":"Heinsbroek","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.03.012_bib14","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/S1473-3099(15)00267-4","article-title":"Genomic epidemiology of age-associated meningococcal lineages in national surveillance: an observational cohort study","volume":"15","author":"Hill","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jinf.2016.03.012_bib15","doi-asserted-by":"crossref","first-page":"19490","DOI":"10.1073\/pnas.1013758107","article-title":"Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines","volume":"107","author":"Donnelly","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2016.03.012_bib16","doi-asserted-by":"crossref","first-page":"e89921","DOI":"10.1371\/journal.pone.0089921","article-title":"Genotypic analysis of meningococcal factor H-binding protein from non-culture clinical specimens","volume":"9","author":"Clark","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2016.03.012_bib17","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1099\/jmm.0.000154","article-title":"Reduced turnaround time and improved diagnosis of invasive serogroup B Neisseria meningitidis and Streptococcus pneumoniae infections using a lyophilized quadruplex quantitative PCR","volume":"64","author":"Mchugh","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.jinf.2016.03.012_bib18","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1099\/mic.0.027995-0","article-title":"Variation of the factor H-binding protein of Neisseria meningitidis","volume":"155","author":"Brehony","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.jinf.2016.03.012_bib19","series-title":"Categorical data analysis","author":"Agresti","year":"1990"},{"key":"10.1016\/j.jinf.2016.03.012_bib20","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.jinf.2015.07.007","article-title":"Genomic resolution of an aggressive, widespread, diverse and expanding meningococcal serogroup B, C and W lineage","volume":"71","author":"Lucidarme","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2016.03.012_bib21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3201\/eid1801.110901","article-title":"Invasive meningococcal capsular group Y disease, England and Wales, 2007\u20132009","volume":"18","author":"Ladhani","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2016.03.012_bib22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/cid\/ciu881","article-title":"Increase in endemic Neisseria meningitidis capsular group W sequence type 11 complex associated with severe invasive disease in England and Wales","volume":"60","author":"Ladhani","year":"2015","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2016.03.012_bib23","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1128\/JCM.00936-09","article-title":"Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales","volume":"47","author":"Lucidarme","year":"2009","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jinf.2016.03.012_bib24","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/IAI.00849-10","article-title":"Effect of factor H-binding protein sequence variation on factor H binding and survival of Neisseria meningitidis in human blood","volume":"79","author":"Dunphy","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2016.03.012_bib25","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1128\/IAI.00891-10","article-title":"Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies","volume":"79","author":"Seib","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2016.03.012_bib26","doi-asserted-by":"crossref","first-page":"e69746","DOI":"10.1371\/journal.pone.0069746","article-title":"Prevalence and phase variable expression status of two autotransporters, NalP and MspA, in carriage and disease isolates of Neisseria meningitidis","volume":"8","author":"Oldfield","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2016.03.012_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1073\/pnas.1321556111","article-title":"Neisseria meningitidis NalP cleaves human complement C3, facilitating degradation of C3b and survival in human serum","volume":"111","author":"Del Tordello","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2016.03.012_bib28","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1073\/pnas.0915162107","article-title":"Neisseria meningitidis GNA2132, a heparin-binding protein that induces protective immunity in humans","volume":"107","author":"Serruto","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jinf.2016.03.012_bib29","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1128\/IAI.01193-09","article-title":"NalP-mediated proteolytic release of lactoferrin-binding protein B from the meningococcal cell surface","volume":"78","author":"Roussel-Jaz\u00e9d\u00e9","year":"2010","journal-title":"Infect Immun"},{"key":"10.1016\/j.jinf.2016.03.012_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.20072577","article-title":"A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies","volume":"205","author":"Uria","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.jinf.2016.03.012_bib31","doi-asserted-by":"crossref","first-page":"e9413","DOI":"10.1371\/journal.pone.0009413","article-title":"The influence of IS1301 in the capsule biosynthesis locus on meningococcal carriage and disease","volume":"5","author":"Kugelberg","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.jinf.2016.03.012_bib32","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.vaccine.2013.01.021","article-title":"A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults","volume":"31","author":"Marshall","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jinf.2016.03.012_bib33","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/INF.0b013e3181f59f6d","article-title":"Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial","volume":"29","author":"Snape","year":"2010","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2016.03.012_bib34","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1097\/INF.0b013e31829aa63b","article-title":"A multi-country evaluation of Neisseria meningitidis serogroup B factor H-binding proteins and implications for vaccine coverage in different age groups","volume":"32","author":"Hoiseth","year":"2013","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jinf.2016.03.012_bib35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1186\/1471-2105-11-595","article-title":"BIGSdb: scalable analysis of bacterial genome variation at the population level","volume":"11","author":"Jolley","year":"2010","journal-title":"BMC Bioinformatics"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445316300081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:22:54Z","timestamp":1759008174000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445316300081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0163445316300081"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2016.03.012","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distribution","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2016.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2016 Published by Elsevier Ltd on behalf of The British Infection Association. All rights reserved.","name":"copyright","label":"Copyright"}]}}